AZ drug combo misses the mark in late-stage lung cancer study
An AstraZeneca immunotherapy has failed to meet its goal in a late-stage study involving patients with advanced non-small cell lung cancer. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 21, 2019 Category: Pharmaceuticals Source Type: news
FDA warns Chinese company for drug manufacturing data integrity violations
The organization sent Ningbo Huize Commodity a warning letter for significant current good manufacturing practice violations, including data integrity issues. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 20, 2019 Category: Pharmaceuticals Source Type: news
Endo and Allergan settle major opiod case for $15 million
The agreement comes ahead of the trial scheduled for October 21, where Purdue, Teva and Johnson& Johnson are still set to face trial (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 20, 2019 Category: Pharmaceuticals Source Type: news
AbbVie ’s Humira follow-up gets FDA nod
A potential new blockbuster from AbbVie has gotten the go-ahead from the FDA. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 19, 2019 Category: Pharmaceuticals Source Type: news
FDA rejects potential jet lag treatment
Vanda Pharmaceuticals announced that it has received a complete response letter from the FDA for its potential treatment for jet lag. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 19, 2019 Category: Pharmaceuticals Source Type: news
Product Focus: Optimizing your ebb and flow
New approaches to fluid control enhance pharma manufacturing (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 19, 2019 Category: Pharmaceuticals Source Type: news
Ebola spreads to remote Congo territory
Authorities in the Democratic Republic of Congo have confirmed a new case of Ebola in the remote, militia-controlled territory of Walikale (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 19, 2019 Category: Pharmaceuticals Source Type: news
Celgene wins key FDA ok ahead of BMS merger
The U.S. FDA has approved Celgene ' s rare bone marrow cancer drug, Inrebic, giving the drugmaker a big regulatory win ahead of its proposed merger with Bristol-Myers Squibb. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 19, 2019 Category: Pharmaceuticals Source Type: news
Pfizer recalls migraine drug for possible microbial contamination
Pfizer has recalled two lots of migraine drug Relpax after finding those lots “may not meet Pfizer’s in-house microbiological specification for the potential presence” of two kinds of bacteria. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 16, 2019 Category: Pharmaceuticals Source Type: news
Pharma innovation: Depends how you slice it
The definition of innovation isn ’t always clear cut (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 15, 2019 Category: Pharmaceuticals Source Type: news
Sanofi wins appeal for Jevtana patent
A federal appeals court affirmed the validity of Sanofi ' s first patent on prostate-cancer drug, Jevtana. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 15, 2019 Category: Pharmaceuticals Source Type: news
Pharma in review: trending stories 8/16/19
Most popular Pharma Manufacturing stories from the past seven days. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 15, 2019 Category: Pharmaceuticals Source Type: news
Top Novartis scientists exited company ahead of data scandal
More details are emerging about the months leading up to Novartis ’s admission that data results for its gene therapy Zolgensma were manipulated. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 14, 2019 Category: Pharmaceuticals Source Type: news
Ovarian cancer drug hits main goal in new study
An AstraZeneca treatment scored an important victory in the quest to offer new treatments for ovarian cancer. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 14, 2019 Category: Pharmaceuticals Source Type: news
Eli Lilly psoriasis drug bests J & amp;J rival
The drugmaker ' s Taltz beat out Johnson& Johnson ' s Tremfya at achieving total skin clearance after 12 weeks of treatment (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 13, 2019 Category: Pharmaceuticals Source Type: news
